Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)] by real time PCR (RT-PCR) and flow cytometry (FC).

被引：0
|
作者：
Perea, G
Lasa, A
Aventin, A
Domingo, A
Villamor, N
de Llano, MPQ
Llorente, A
Junca, J
Palacios, C
Fernandez, C
Gilallart, M
Font, L
Tormo, M
Florensa, L
Bargay, J
Marti, JM
Vivancos, P
Torres, P
Berlanga, J
Brunet, S
Sierra, J
Nomdedeu, JF
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Bellvitge Hosp, Hosp Llobregat, Barcelona, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Virgen Victoria, Malaga, Spain
[5] Hosp Joan 23, Tarragona, Spain
[6] Hosp Germans Trias & Pujol, Badalona, Spain
[7] Hosp Gen Valle Hebron, Barcelona, Spain
[8] Hosp Josep Trueta, Girona, Spain
[9] Hosp Arnau Vilanova, Lerida, Spain
[10] Hosp Verge Cinta, Tarragona, Spain
[11] Hosp Clin, Valencia, Spain
[12] Hosp Mer, Barcelona, Spain
[13] Hosp Son Llatzer, Mallorca, Spain
[14] Mutua Terrassa, Barcelona, Spain
[15] Clin Teknon, Barcelona, Spain
[16] Hosp Juan Canalejo, La Coruna, Spain
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2989.2989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2989
引用
收藏
页码：817A / 817A
页数：1
相关论文
共 50 条
  • [1] Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]
    G Perea
    A Lasa
    A Aventín
    A Domingo
    N Villamor
    M Paz Queipo de Llano
    A Llorente
    J Juncà
    C Palacios
    C Fernández
    M Gallart
    L Font
    M Tormo
    L Florensa
    J Bargay
    J M Martí
    P Vivancos
    P Torres
    J J Berlanga
    I Badell
    S Brunet
    J Sierra
    J F Nomdedéu
    Leukemia, 2006, 20 : 87 - 94
  • [2] Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]
    Perea, G
    Lasa, A
    Aventín, A
    Domingo, A
    Villamor, N
    de Llano, MPQ
    Llorente, A
    Juncà, J
    Palacios, C
    Fernández, C
    Gallart, M
    Font, L
    Tormo, M
    Florensa, L
    Bargay, J
    Martí, JM
    Vivancos, P
    Torres, P
    Berlanga, JJ
    Badell, I
    Brunet, S
    Sierra, J
    Nomdedéu, JF
    LEUKEMIA, 2006, 20 (01) : 87 - 94
  • [3] Detection of minimal residual disease (MRD) by RT-PCR in childhood acute myeloid leukemia (AML).
    Viehmann, S
    Creutzig, U
    Borkhardt, A
    Blütters-Sawatzki, R
    Harbott, J
    BLOOD, 1999, 94 (10) : 215B - 215B
  • [4] Monitoring of minimal residual disease (MRD) by RT-PCR in childhood acute myeloid leukemia (AML) with AML1/ETO rearrangement
    Viehmann, S
    Creutzig, U
    Borkhardt, A
    Harbott, J
    LEUKEMIA, 2001, 15 (12) : 2025 - 2025
  • [5] Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCR
    Tobal, K
    Yin, JAL
    LEUKEMIA & LYMPHOMA, 1998, 31 (1-2) : 115 - 120
  • [6] Monitoring of minimal residual disease in patients with acute myeloid leukemia (AML) and translocation (8;21) or inversion (16) by reverse transcriptase polymerase chain reaction (RT-PCR)
    Schafthausen, P
    Schoch, R
    Haferlach, T
    Nickelsen, M
    Jenisch, S
    Kronke, M
    Gassmann, W
    Loffler, H
    BLOOD, 1995, 86 (10) : 1316 - 1316
  • [7] Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR
    Sugimoto, T
    Das, H
    Imoto, S
    Murayama, T
    Gomyo, H
    Chakraborty, S
    Taniguchi, R
    Isobe, T
    Nakagawa, T
    Nishimura, R
    Koizumi, T
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 64 (02) : 101 - 106
  • [8] Qualitative and quantitative RT-PCR in monitoring of minimal residual disease in acute myeloblastic leukemia with translocation t(8;21)
    Fleishman, EV
    Kosorukova, IS
    Sokova, OI
    Popa, AV
    Baturina, YA
    Misyurina, OY
    Ilyina, EN
    Govorun, VM
    Kirichenko, OP
    Konstantinova, LN
    Maschan, AA
    Maschan, MA
    Novichkova, GA
    Baidildina, DD
    Shamansky, SV
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2006, 51 (01): : 3 - 12
  • [9] AML1/MTG8 real time RT-PCR for the detection of minimal residual disease in patients with T(8;21) positive AML.
    Krauter, J
    Wattjes, M
    Nagel, S
    Heidenreich, O
    Bunjes, D
    Bergmann, L
    Heil, G
    Ganser, A
    BLOOD, 1998, 92 (10) : 74A - 75A
  • [10] Evaluation of minimal residual disease using RT-PCR in 37 t (8,21) AML patients
    Morschhauser, F
    Cayuela, JM
    Martini, S
    Baruchel, A
    Rousselot, P
    Socié, G
    Jouet, JP
    Straetmans, N
    Martiat, P
    Fenaux, P
    Preudhomme, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 99 - 99
12345